Bladder cancer Board decisions

The Board has determined that the evidence is at least in relative equipoise as to whether the Veteran's Obstructive Sleep Apnea was aggravated by his service-connected Bladder Cancer, and thus grants service connection for this condition.

The Board has granted service connection for multiple myeloma, bladder cancer, anemia, peripheral neuropathy of the right arm, left arm, right leg, and left leg on a presumptive basis due to in-service exposure to herbicide agents. The Veteran's appeals for service connection for disabilities of the elbows, right ankle, and left arm/wrist have been withdrawn.

The Board denied the Veteran's requests for an effective date prior to August 5, 2009, for the grant of service connection for bladder cancer and SMC for loss of use of a creative organ. The effective dates were found to be August 5, 2009.

The Veteran's prostate cancer and bladder cancer are presumed to be related to his in-service exposure to Agent Orange, thus service connection is granted for both conditions.

The Veteran's bladder cancer is not related to chemical or toxin exposure at Fort McClellan and the Board finds no evidence of service connection.

The Board has granted the Veteran's TDIU claim, finding that his service-connected disabilities render him unable to secure and maintain substantially gainful employment.

The Veteran's bladder cancer with voiding dysfunction is granted a 60 percent rating prior to January 8, 2019. On and after that date, the claim for an increased rating remains denied. The case is remanded for further action on TDIU.

Your claim for service connection for bladder cancer has been granted and effective since February 21, 2018. The Board does not have jurisdiction to make a decision on this issue as the benefit sought is already granted.

The Veteran's bladder cancer claim is being remanded for a new examination to determine if it is at least as likely as not related to in-service exposure to depleted uranium.

The Veteran's GAD and erectile dysfunction are granted effective dates prior to the specified dates, while their bladder cancer is remanded for further evaluation.

The Veteran's bladder cancer is granted service connection as due to exposure to herbicide agents. The appeals for peripheral neuropathy are dismissed.

The Board denied the claim for service connection for the cause of the Veteran's death due to bladder cancer, finding that there was no evidence linking the condition to his service, including exposure to ionizing radiation.

The Board has remanded the case due to insufficient development and lack of substantial compliance with prior remand directives. The Veteran's bladder cancer is being reviewed for potential service connection based on Agent Orange exposure, but a supplemental opinion from an oncologist or physician is needed.

The Board has remanded the cases for further development and to obtain medical opinions regarding whether the Veteran's COPD, bladder cancer, or heart condition are related to his military service. The claims will be reviewed based on the new evidence.

The Veteran's bladder cancer is found to be related to his in-service exposure to chemicals, specifically trichloroethylene and naptha. The Board granted service connection for the condition.

The Veteran's bladder cancer treatment regimen included Bacillus Calmette-Guerin (BCG) immunotherapy from March 14, 2017, to August 31, 2021. The Board granted a 100 percent initial evaluation for service-connected residuals of bladder cancer from March 14, 2017, to August 31, 2021. However, the Veteran's appeal is remanded for further development regarding an initial evaluation in excess of 20 percent from September 1, 2021.

The Board denied the Veteran's claim for service connection for bladder cancer, finding that his condition was not caused by in-service exposure to ionizing radiation and did not manifest during or within one year after separation from service.

The Board has granted service connection for gastroesophageal reflux disease (GERD) with duodenal bulb scarring, but denied service connection for basal cell carcinoma, bladder cancer, non-Hodgkin's lymphoma, and prostate cancer due to lack of evidence linking these conditions to in-service exposure or service.

The Veteran's bladder cancer is related to his exposure to herbicide agents, specifically Agent Orange. His claim for service connection has been granted.

The Veteran's claim for service connection for bladder cancer was granted in a January 2022 rating decision, and the appeal is dismissed as there are no longer any disputed issues.